Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Castration-resistant prostate cancer is a late stage disease and many people die of it due to lack of effective therapeutic drugs. In the current project, we propose to develop new therapeutic drug a to specifically target CRPCs common weak points, which are MCT4 and eIF4E genes proteint products that play very important roles in regulation of cancer cells energetic and protein translation pathways. The project aims to develop an antibody drug, an small molecule chemical drug and a nanoparticle drug to target MCT4 membrane protein and eIF4E transcription factor protein. If successful, the project will lead to new drug development for treating this deadly disease.
Yuzhuo Wang
Faline Yang
Pharmaplanter Technologies Inc
Visual arts
Pharmaceuticals
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.